InsiderTrades

Form 4 for BDTX Black Diamond Therapeutics, Inc.

Accepted 2025-03-20 00:00:00 ET · period of report 2025-03-19 · accession 0001104659-25-026305 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-03-20 2025-03-19 BDTX BIOTECH GROWTH N V 10% S - Sale $2.07 -5.78M 3.23M -64% -$12.00M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-19 S D 400,000 $2.09 3,817,839 D — —
2 Common Common Stock 2025-03-19 S D 500,000 $2.12 2,733,547 D — —
3 Common Common Stock 2025-03-19 S D 1,000,000 $2.07 7,517,839 D — —
4 Common Common Stock 2025-03-19 S D 2,000,000 $2.00 4,217,839 D — —
5 Common Common Stock 2025-03-19 S D 1,000,000 $2.31 6,217,839 D — —
6 Common Common Stock 2025-03-19 S D 300,000 $1.94 7,217,839 D — —
7 Common Common Stock 2025-03-19 S D 584,292 $1.95 3,233,547 D — —